AKT-022 is under clinical development by Aquavit Pharmaceuticals and currently in Phase III for Unspecified Dermatological Disorders.

Opzelura is under clinical development by Incyte and currently in Phase II for Unspecified Dermatological Disorders.

VMPL New Delhi [India] January 4 Exosomes have long been studied in the global skincare and medical fields for their ...

Hair loss is a common concern that often intensifies during the winter months. As a dermatologist, I frequently meet patients ...

This beauty hack is amazing for getting rid of those pesky sun spots. Here's a step-by-step guide on how to use it.

Dr. Petit, a dermatology clinic specializing in skin beauty, announced on the 1st that it has launched the Dermaskincare ...

Whether it's cold air outdoors or hot air inside, health experts say the shift in the weather can affect the skin.

Regenerative Dermatology Company Successfully Applies "Injury Mimetic" Stimulated Stem Cell Grafts to Treatment of Third Largest Cause of Death in USA SAN ...

Dermatologists evaluate moles based on specific criteria when determining whether removal is appropriate. While some patients seek removal for cosmeti ...

The RMIC reported that remote consultations were most commonly used for mild ailments, such as acne, atopic dermatitis, and ...

Dr. Jason Emer in New York Office Dr. Jason Emer, a leader in cosmetic and dermatological innovation, announces the expansion of his p ...

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...